Lipid–Polymer Hybrid Nanoparticle-Based Combination Treatment with Cisplatin and EGFR/HER2 Receptor-Targeting Afatinib to Enhance the Treatment of Nasopharyngeal Carcinoma

Lipid–Polymer Hybrid Nanoparticle-Based Combination Treatment with Cisplatin and EGFR/HER2 Receptor-Targeting Afatinib to Enhance the Treatment of Nasopharyngeal Carcinoma

Dehui Fu, Chao Li, Yongwang Huang Department of Ear-Nose-Throat (ENT), The Second Hospital of Tianjin Medical University, Tianjin, 300211, People’s Republic of ChinaCorrespondence: Yongwang HuangDepartment of Ear-Nose-Throat, The Second Hospital of Tianjin Medical University, No. 23 Pingji...

Full description

Bibliographic Details
Main Authors: Fu D, Li C, Huang Y
Format: Article
Language:English
Published: Dove Medical Press 2021-04-01
Series:OncoTargets and Therapy
Subjects:
nasopharyngeal carcinoma
cisplatin
afatinib
nanoparticles
antitumor
apoptosis
Online Access:https://www.dovepress.com/lipidndashpolymer-hybrid-nanoparticle-based-combination-treatment-with-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/lipidndashpolymer-hybrid-nanoparticle-based-combination-treatment-with-peer-reviewed-article-OTT

Similar Items